MedPath

S-892216

Generic Name
S-892216

A Study of S-892216 in Participants With COVID-19

Phase 2
Not yet recruiting
Conditions
COVID-19
Interventions
Drug: Placebo
First Posted Date
2025-04-15
Last Posted Date
2025-05-06
Lead Sponsor
Shionogi
Target Recruit Count
280
Registration Number
NCT06928051

A Drug-drug Interaction Study of S-892216 Coadministered With Carbamazepime to Healthy Adult Participants

Phase 1
Completed
Conditions
COVID-19
Interventions
First Posted Date
2024-12-27
Last Posted Date
2025-03-11
Lead Sponsor
Shionogi
Target Recruit Count
16
Registration Number
NCT06751017
Locations
🇺🇸

ICON Lenexa, Lenexa, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath